Question 1

What is the catalog number for Methyl 2- (2-chloropropanamido) acetate?

Accepted Answer

The catalog number for Methyl 2- (2-chloropropanamido) acetate is MHA80452.

Question 2

What sizes are available for Methyl 2- (2-chloropropanamido) acetate?

Accepted Answer

Methyl 2- (2-chloropropanamido) acetate is available in the following size(s): 100 mg, 1 g.

Question 3

How many pack sizes does Methyl 2- (2-chloropropanamido) acetate come in?

Accepted Answer

Methyl 2- (2-chloropropanamido) acetate is available in 2 different pack sizes.

Question 4

Is Methyl 2- (2-chloropropanamido) acetate in stock?

Accepted Answer

Methyl 2- (2-chloropropanamido) acetate is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 6

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 7

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Methyl 2- (2-chloropropanamido) acetate

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

Human Matrix Metalloproteinase 19 (MMP19) ELISA Kit

Human Matrix Metalloproteinase 19 (MMP19) ELISA Kit

1,3-Adamantanedicarboxylic acid

Tissue FFPE Sections, Kidney

Human FYCO1 activation kit by CRISPRa

EMP2 Human Gene Knockout Kit (CRISPR)